Form 8-K · Current report
Zimmer Biomet 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0001136869
- Accession no.
- 0001193125-26-335108
Summary
Zimmer Biomet filed a Form 8-K recasting portions of its 2025 annual report to reflect a change in operating segment composition, under which results of its Foot and Ankle business in EMEA and Asia Pacific and certain product category expenses such as centralized R&D and global marketing are now included in the Americas operating segment. The filing states it is not an amendment to or restatement of the 2025 Form 10-K and makes no other updates.
Key points
- The recast covers Part II, Item 7 (Management's Discussion and Analysis) and Part II, Item 8 (Financial Statements and Supplementary Data) of the 2025 Form 10-K.
- The segment changes followed a change in the responsibilities of senior leaders reporting to the chief operating decision maker in the quarter ended March 31, 2026.
- Exhibit 99.1 contains the recast sections; the exhibit index also lists a consent of PricewaterhouseCoopers LLP and inline XBRL documents.
- Zimmer Biomet states the information in Exhibit 99.1 is not an amendment to, or a restatement of, the 2025 Form 10-K.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. Zimmer Biomet Holdings, Inc. (“we,” “us,” “our,” the “Company” and other similar words) is filing this Current Report on Form 8-K, including Exhibit 99.1, solely to recast certain financial information and related disclosures included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 20, 2026 (the “2025 Form 10-K”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.